The Oncogenomics Handbook

In The Oncogenomics Handbook, a panel of internationally recognized researchers and clinicians provides an integrated overview of cancer drug discovery and development from the bench to the clinic, showing with broad strokes and ...

Author: William J. LaRochelle

Publisher: Springer Science & Business Media

ISBN: 9781592598939

Category: Medical

Page: 750

View: 983

DOWNLOAD →

An integrated overview of cancer drug discovery and development from the bench to the clinic, showing with broad strokes and representative examples the drug development process as a network of linked components leading from the discovered target to the ultimate therapeutic product. Following a systems biology approach, the authors explain genomic databases and how to discover oncological targets from them, how then to advance from the gene and transcript to the level of protein biochemistry, how next to move from the chemical realm to that of the living cell and, ultimately, pursue animal modeling and clinical development. Emerging cancer therapeutics including Ritux an, Erbitux, Gleevec Herceptin, Avastin, ABX-EGF, Velcade, Kepivance, Iressa, Tarceva, and Zevalin are addressed. Highlights include cancer genomics, pharmacogenomics, transcriptomics, gene expression analysis, proteomic and enzymatic cancer profiling technologies, and cellular and animal approaches to cancer target validation.

Handbook of Oncogenomics

This book, with its detailed analyses and data, will prove immensely beneficial to professionals and students involved in this area at various levels.

Author: Zena Murray

Publisher: American Medical Publishers

ISBN: 1639272518

Category: Medical

Page: 229

View: 975

DOWNLOAD →

The accumulation of DNA mutations and epigenetic variations that leads to uncontrolled cell proliferation and formation of neoplasm refers to cancer. It is a genetic disease. The sub branch of genomics that deals with the study of cancer related genes is known as oncogenomics. The primary goal of the discipline is to recognize new tumor suppressor genes and oncogenes that may lead to new insights in the diagnosis of cancer, help predict the clinical outcome of different cancers and identify new targets for cancer therapies. It uses the techniques of transciptomes, genome sequencing, bioinformatics, functional analysis of oncogenes, etc. The field is also concerned with personalizing cancer treatment by identifying and targeting mutations in an individual patient. The book elucidates the concepts and innovative models around the prospective developments with respect to oncogenomics. The various studies that are constantly contributing towards advancing technologies and evolution of this field are examined in detail. This book, with its detailed analyses and data, will prove immensely beneficial to professionals and students involved in this area at various levels.

Bone Metastasis

Bone Metastasis: Experimental and Clinical Therapeutics, edited by Gurmit Singh and Shafaat A. Rabbani, 2005 Death Receptors in Cancer Therapy, edited by Wafik S. El-Deiry, 2005 The Oncogenomics Handbook, edited by William J. LaRochelle ...

Author: Gurmit Singh

Publisher: Springer Science & Business Media

ISBN: 9781592598922

Category: Medical

Page: 344

View: 426

DOWNLOAD →

A state-of-the-art review of the molecular underpinnings of bone-seeking cancers, current treatment approaches for them, and future therapeutic strategies. The authors illuminate the role of various autocrine, paracrine, and immunological factors involved in the progression and establishment of bone metastases, highlighting the physiological processes that lead to bone degradation, pain, angiogenesis, and dysregulation of bone turnover. They also discuss the various strategies that appear to have promise and are currently deployed in treatment or are at the experimental stage.

Protein Tyrosine Kinases

El-Deiry, 2005 Bone Metastasis: Experimental and Clinical Therapeutics, edited by Gurmit Singh and Shafaat A. Rabbani, 2005 The Oncogenomics Handbook, edited by William J. LaRochelle and Richard A. Shimkets, 2005 Camptothecins in Cancer ...

Author: Doriano Fabbro

Publisher: Springer Science & Business Media

ISBN: 9781592599622

Category: Science

Page: 290

View: 456

DOWNLOAD →

Leading researchers, from the Novartis group that pioneered Gleevec/GlivecTM and around the world, comprehensively survey the state of the art in the drug discovery processes (bio- and chemoinformatics, structural biology, profiling, generation of resistance, etc.) aimed at generating PTK inhibitors for the treatment of various diseases, including cancer. Highlights include a discussion of the rationale and the progress made towards generating "selective" low molecular-weight kinase inhibitors; an analysis of the normal function, role in disease, and application of platelet-derived growth factor antagonists; and a summary of the factors involved in successful structure-based drug design. Additional chapters address the advantages and disadvantages of in vivo preclinical models for testing protein kinase inhibitors with antitumor activity and the utility of different methods in the drug discovery and development process for determining "on-target" vs "off-target" effects of kinase inhibitors.

Cancer Drug Resistance

... 2005 The Oncogenomics Handbook, edited by William J. LaRochelle and Richard A. Shimkets, 2005 Camptothecins in Cancer Therapy, edited by Thomas G. Burke and Val R. Adams, 2005 Combination Cancer Therapy: Modulators and Potentiators, ...

Author: Beverly A. Teicher

Publisher: Springer Science & Business Media

ISBN: 9781597450355

Category: Medical

Page: 617

View: 984

DOWNLOAD →

Leading experts summarize and synthesize the latest discoveries concerning the changes that occur in tumor cells as they develop resistance to anticancer drugs, and suggest new approaches to preventing and overcoming it. The authors review physiological resistance based upon tumor architecture, cellular resistance based on drug transport, epigenetic changes that neutralize or bypass drug cytotoxicity, and genetic changes that alter drug target molecules by decreasing or eliminating drug binding and efficacy. Highlights include new insights into resistance to antiangiogenic therapies, oncogenes and tumor suppressor genes in therapeutic resistance, cancer stem cells, and the development of more effective therapies. There are also new findings on tumor immune escape mechanisms, gene amplification in drug resistance, the molecular determinants of multidrug resistance, and resistance to taxanes and Herceptin.

Immunotherapy of Cancer

... 2005 The Oncogenomics Handbook, edited by William J. LaRochelle and Richard A. Shimkets, 2005 Camptothecins in Cancer Therapy, edited by Thomas G. Burke and Val R. Adams, 2005 Combination Cancer Therapy: Modulators and Potentiators, ...

Author: Mary L. Disis

Publisher: Springer Science & Business Media

ISBN: 9781597450119

Category: Medical

Page: 516

View: 555

DOWNLOAD →

Expert bench and clinical scientists join forces to concurrently review both the state-of-the-art in tumor immunology and its clinical translation into promising practical treatments. The authors explain in each chapter the scientific basis behind such therapeutic agents as monoclonal antibodies, cytokines, vaccines, and T-cells, and illustrate their clinical manipulation to combat cancer. Additional chapters address statistical analysis-both of clinical trials and assay evaluations-methods for the discovery of antigens, adoptive T cell therapy, and adaptive and innate immunity. The challenges in clinical trial design, the need for biomarkers of response-such as novel imaging techniques and immunologic monitoring-and the new advances and directions in cancer immunotherapy are also fully examined.

Antiangiogenic Agents in Cancer Therapy

... 2005 The Oncogenomics Handbook, edited by William J. LaRochelle and Richard A. Shimkets, 2005 Camptothecins in Cancer Therapy, edited by Thomas G. Burke and Val R. Adams, 2005 Combination Cancer Therapy: Modulators and Potentiators, ...

Author: Beverly A. Teicher

Publisher: Springer Science & Business Media

ISBN: 9781597451840

Category: Medical

Page: 559

View: 574

DOWNLOAD →

This volume represents a compendium of scientific findings and approaches to the study of angiogenesis in cancer. The second edition of Antiangiogenic Agents in Cancer Therapy is intended to give a current perspective on the state-of-the-art of angiogenensis and therapy directed at this process. Antiangiogenesis is a dynamic and evolving field in oncology. New therapeutic targets continue to emerge followed by the rapid development of new therapeutic agents to be investigated in clinical trials. Optimizing the therapeutic potential of antiangiogenic agents in combination with the other therapies in the armamentarium to fight cancer will be an on-going challenge.

Death Receptors in Cancer Therapy

Death Receptors in Cancer Therapy, edited by Wafik S. El-Deiry, 2005 Bone Metastasis: Experimental and Clinical Therapeutics, edited by Gurmit Singh and Shafaat A. Rabbani, 2005 The Oncogenomics Handbook, edited by William J. LaRochelle ...

Author: Wafik S. El-Deiry

Publisher: Springer Science & Business Media

ISBN: 9781592598519

Category: Medical

Page: 374

View: 456

DOWNLOAD →

An in depth review of our latest understanding of the molecular events that regulate cell death and those molecules that provide targets for developing agonists or antagonists to modulate death signaling for therapeutic purposes. The authors focus on the extrinsic system of death receptors, their regulation and function, and their abnormalities in cancer. Topics of particular interest include resistance to apoptosis, TRAIL signaling, death receptors in embryonic development, mechanisms of caspase activation, and death receptor mutations in cancer. Additional chapters address death signaling in melanoma, synthetic retinoids and death receptors, the role of p53 in death receptor regulation, immune suppression of cancer, and combination therapy with death ligands.

Regional Cancer Therapy

... 2005 The Oncogenomics Handbook, edited by William J. LaRochelle and Richard A. Shimkets, 2005 Camptothecins in Cancer Therapy, edited by Thomas G. Burke and Val R. Adams, 2005 Combination Cancer Therapy: Modulators and Potentiators, ...

Author: Peter M. Schlag

Publisher: Springer Science & Business Media

ISBN: 9781597452250

Category: Medical

Page: 455

View: 116

DOWNLOAD →

This volume provides a biological and pharmacological background for regional cancer therapy, strategies and techniques for regional therapies, and specific indications and results for different tumor entities. Clinical trial concepts and detailed treatment protocols are also presented. This book is essential reading for researchers and clinicians engaged in seeking advanced therapeutic options for cancer patients worldwide.

Histone Deacetylases

... 2005 The Oncogenomics Handbook, edited by William J. LaRochelle and Richard A. Shimkets, 2005 Camptothecins in Cancer Therapy, edited by Thomas G. Burke and Val R. Adams, 2005 Combination Cancer Therapy: Modulators and Potentiators, ...

Author: Eric Verdin

Publisher: Springer Science & Business Media

ISBN: 9781597450249

Category: Medical

Page: 352

View: 920

DOWNLOAD →

A panel of leading investigators summarizes and synthesizes the new discoveries in the rapidly evolving field of histone acetylation as a key regulatory mechanism for gene expression. The authors describe what has been learned about these proteins, including the identification of the enzymes, the elucidation of the enzymatic mechanisms of action, and the identification of their substrates and their partners. They also review the structures that have been solved for a number of enzymes-both alone and in complex with small molecule inhibitors-and the biological roles of the several histone deacetylases (HDAC) genes that have been knocked out in mice.